Cargando…

Immunosenescence and Immune Exhaustion Are Associated with Levels of Protein-Bound Uremic Toxins in Patients on Hemodialysis

Background: The accumulation of protein-bound uremic toxins (PBUTs) in chronic kidney disease may affect patients’ immune status. The aim of the study was to evaluate their potential impacts on lymphocyte alterations in patients on hemodialysis (HD). Methods: The plasma levels of PBUTs were assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tourountzis, Theodoros, Lioulios, Georgios, Van Laecke, Steven, Ginikopoulou, Evdoxia, Nikolaidou, Vasiliki, Moysidou, Eleni, Stai, Stamatia, Christodoulou, Michalis, Fylaktou, Asimina, Glorieux, Griet, Stangou, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525954/ https://www.ncbi.nlm.nih.gov/pubmed/37760945 http://dx.doi.org/10.3390/biomedicines11092504

Ejemplares similares

Different Types of Chronic Inflammation Engender Distinctive Immunosenescent Profiles in Affected Patients
por: Moysidou, Eleni, et al.
Publicado: (2022)

Exhausted but Not Senescent T Lymphocytes Predominate in Lupus Nephritis Patients
por: Lioulios, Georgios, et al.
Publicado: (2022)

COVID-19 Infection and Response to Vaccination in Chronic Kidney Disease and Renal Transplantation: A Brief Presentation
por: Stai, Stamatia, et al.
Publicado: (2022)

Microbiome in Chronic Kidney Disease
por: Tourountzis, Theodoros, et al.
Publicado: (2022)

Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis
por: Konstantouli, Afroditi Maria, et al.
Publicado: (2022)

Relapse of Monoclonal Gammopathy of Renal Significance after mRNA COVID-19 Vaccination: A Case Report
por: Tsaftaridis, Nikolaos, et al.
Publicado: (2023)

Effect of Lymphocyte Phenotypic Alterations on the Humoral Response to Vaccination Against SARS-COV-2 in Dialysis Patients
por: Lioulios, Georgios, et al.
Publicado: (2023)

Increase in Double Negative B Lymphocytes in Patients with Systemic Lupus Erythematosus in Remission and Their Correlation with Early Differentiated T Lymphocyte Subpopulations
por: Moysidou, Eleni, et al.
Publicado: (2023)

From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?
por: Stai, Stamatia, et al.
Publicado: (2022)

Prospective Analysis of B Lymphocyte Subtypes, before and after Initiation of Dialysis, in Patients with End-Stage Renal Disease
por: Daikidou, Dimitra-Vasilia, et al.
Publicado: (2023)

ANCA-Associated Vasculitis May Result as a Complication to Both SARS-CoV-2 Infection and Vaccination
por: Christodoulou, Michalis, et al.
Publicado: (2022)

Humoral and Cellular Immunity Are Significantly Affected in Renal Transplant Recipients, following Vaccination with BNT162b2
por: Fylaktou, Asimina, et al.
Publicado: (2023)

Immune Profile Determines Response to Vaccination against COVID-19 in Kidney Transplant Recipients
por: Stai, Stamatia, et al.
Publicado: (2023)

Editorial: Immunosenescence and Immunoexhaustion in Chronic Kidney Disease and Renal Transplantation
por: Stangou, Maria J., et al.
Publicado: (2022)

What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008)

Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis
por: Spartalis, Michalis, et al.
Publicado: (2023)

CD28null and Regulatory T Cells Are Substantially Disrupted in Patients with End-Stage Renal Disease Due to Diabetes Mellitus
por: Sampani, Erasmia, et al.
Publicado: (2021)

Different Types of ANCA Determine Different Clinical Phenotypes and Outcome in ANCA-Associated Vasculitis (AAV)
por: Bantis, Kostas, et al.
Publicado: (2022)

Clustering of End Stage Renal Disease Patients by Dimensionality Reduction Algorithms According to Lymphocyte Senescence Markers
por: Lioulios, Georgios, et al.
Publicado: (2022)

Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes
por: Deltombe, Olivier, et al.
Publicado: (2019)

Effect of panel reactive antibodies on T cell immunity reinstatement following renal transplantation
por: Vagiotas, Lampros, et al.
Publicado: (2022)

Histology and Immunohistochemistry of Radial Arteries Are Suggestive of an Interaction between Calcification and Early Atherosclerotic Lesions in Chronic Kidney Disease
por: Lysitska, Aikaterini, et al.
Publicado: (2021)

Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis
por: Eloot, Sunny, et al.
Publicado: (2016)

Immunosenescence: an unexplored role in glomerulonephritis
por: Van Laecke, Steven, et al.
Publicado: (2022)

Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease
por: Chinnappa, Shanmugakumar, et al.
Publicado: (2018)

Plasma exchange and COVID 19
por: Ginikopoulou, Evdoxia
Publicado: (2022)

Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
por: Boziki, Marina, et al.
Publicado: (2022)

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
por: Liabeuf, Sophie, et al.
Publicado: (2013)

Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2021)

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
por: Vanholder, Raymond, et al.
Publicado: (2018)

Two Cases of Autoimmune Thyroid Disorders after COVID Vaccination in Dialysis Patients
por: Lioulios, Georgios, et al.
Publicado: (2022)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022)

Exploring Perturbations in Peripheral B Cell Memory Subpopulations Early after Kidney Transplantation Using Unsupervised Machine Learning
por: Fouza, Ariadni, et al.
Publicado: (2023)

Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes
por: Mutsaers, Henricus A. M., et al.
Publicado: (2015)

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
por: Vanholder, Raymond, et al.
Publicado: (2008)

Cellular and Humoral Responses in Dialysis Patients after Vaccination with the BNT162b2 or mRNA-1273 Vaccines
por: Mavrovouniotis, Ilias, et al.
Publicado: (2023)

Does the Adequacy Parameter Kt/V(urea) Reflect Uremic Toxin Concentrations in Hemodialysis Patients?
por: Eloot, Sunny, et al.
Publicado: (2013)

Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
por: Deltombe, Olivier, et al.
Publicado: (2015)

Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
por: Vanholder, Raymond, et al.
Publicado: (2018)

Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients
por: Gryp, Tessa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2h2gqvp8d8es1nj0eplnells9k